Trials / Unknown
UnknownNCT06170918
Dose of Remimazolam in Children for Intubation
Half Effective Dose of Remimazolam to Prevent Cardiovascular Response to Tracheal Intubation When Combined With Fentanyl
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Zhihong LU · Academic / Other
- Sex
- All
- Age
- 3 Years – 12 Years
- Healthy volunteers
- Not accepted
Summary
Remimazolam has demonstrated the potential as a valuable medication for procedural sedation and general anesthesia. However, half effective dose of remimazolam required to prevent cardiovascular response to tracheal intubation when combined with fentanyl in pediatric patients is still unknown.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Remimazolam | remimazolam is given intravenously |
Timeline
- Start date
- 2023-12-20
- Primary completion
- 2024-05-31
- Completion
- 2024-05-31
- First posted
- 2023-12-14
- Last updated
- 2023-12-14
Source: ClinicalTrials.gov record NCT06170918. Inclusion in this directory is not an endorsement.